Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
Award amountNot stated
Health human services grants for school districts
The intersection of two stored fields: the eligible-applicant field includes k-12 & school district, including records the funder marked open to any applicant, and the industry field is Health human services.
Records linked714In this slice
Median award ceiling$500,000Computed from 242 of 714 records with a stated ceiling
Award ceiling range$0 – $250,000,000Lowest stated floor to highest stated ceiling
Program pools (total)$8,541,919,574Sum of programme totals across 301 records. Not an amount any applicant receives.
Next linked deadlines
Placement and Coordination ProgramSep 17, 2026
387 of 714 records carry a stated deadline; 0 are rolling and the rest read Not stated.
Funder type distribution
Federal714
Counted from linked records only.
Displaying 201 – 225 of 714
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)
Award amountNot stated
NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)
Award amountNot stated
NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
Award amountNot stated
NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
Award amountNot stated
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
Award range$50,000 – $300,000
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
Award amountNot stated
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
Award ceilingup to $750,000
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)
Award ceilingup to $750,000
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
Award amountNot stated
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
Award amountNot stated
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)
Award amountNot stated
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)
Award amountNot stated
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
Award ceilingup to $1,500,000
Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required)
Award amountNot stated
Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
Award amountNot stated
BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
Award amountNot stated
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)
Award amountNot stated
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)
Award amountNot stated
NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)
Award amountNot stated
Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)
Award amountNot stated
Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)
Award ceilingup to $6,250,000
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
Award ceilingup to $200,000
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
Award amountNot stated
Other applicant types
Related industries
Other funding levels
Applicant type in a state
Elsewhere in the library